Southend University Hospital Foundation NHS Trust   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Southend-on-Sea United Kingdom (1888)

Organization Overview

First Clinical Trial
2012
NCT01608009
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Southend University Hospital | Southend University Hospital NHS Foundation Trust

Active Ingredients

Drugs in Phase 3 Trials (2)

anakinra (Kineret) (1 trial)

methylprednisolone (medrol) (1 trial)

Drugs in Phase 2 Trials (2)

carboplatin (paraplatin) (1 trial)

oxcarbazepine (trileptal) (1 trial)

Drugs in Phase 1 Trials (2)

paclitaxel (taxol) (1 trial)

pazopanib (votrient) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Ovarian Epithelial (Phase 1)

Gout (Phase 3)

Kidney Diseases (Phase 3)

Multiple Sclerosis (Phase 2)

Ovarian Neoplasms (Phase 1)

Prostatic Neoplasms (Phase 2)

Renal Insufficiency, Chronic (Phase 3)

Sclerosis (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 6